Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parham Sendi

Showing results (111-120 of 161) with videos related to

Pageof 17
Sort By:
Frontiers in Microbiology|June 6, 2018
Is Penicillin Plus Gentamicin Synergistic Against Sessile Group B Streptococcal Isolates? An <i>in Vivo</i> Study With an Experimental Model of Foreign-Body InfectionCorinne Ruppen, Thomas Mercier, Denis Grandgirard, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 2024
Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infectionLaura Hermann, Verena Schöning, Sarah Dräger, et al.
Journal of Global Antimicrobial Resistance|October 31, 2021
Repatriation of a patient with COVID-19 contributed to the importation of an emerging carbapenemase producerAline I Moser, Edgar I Campos-Madueno, Parham Sendi, et al.
Springerplus|March 31, 2016
Mycoplasma-induced minimally conscious stateThomas Horvath, Urs Fischer, Lionel Müller, et al.
The Journal of Antimicrobial Chemotherapy|April 16, 2021
Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: a prospective cohort study of unbound plasma and individual MICsStephan Moser, Sophia Rehm, Nicolas Guertler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2023
Rifampin Based Therapy for Patients With Staphylococcus aureus Native Vertebral Osteomyelitis: A Systematic Review and Meta-analysisSaid El Zein, Elie F Berbari, Matteo Passerini, et al.
Infection and Immunity|May 21, 2008
Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humansLinda Johansson, Pontus Thulin, Parham Sendi, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2019
First Clinical Case of <i>In Vivo</i> Acquisition of DHA-1 Plasmid-Mediated AmpC in a Salmonella enterica subsp. <i>enterica</i> IsolateMathieu Clément, Peter M Keller, Odette J Bernasconi, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2015
In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to CefepimeJoão Pires, Magdalena Taracila, Christopher R Bethel, et al.
Antibiotics (Basel, Switzerland)|May 27, 2023
Penicillin-Susceptible <i>Streptococcus pneumoniae</i> Meningitis in Adults: Does the Ceftriaxone Dosing Matter?Samuel Raemy, Carlo Casanova, Rossella Baldan, et al.
Pageof 17

Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
Frontiers in Microbiology|June 6, 2018
Is Penicillin Plus Gentamicin Synergistic Against Sessile Group B Streptococcal Isolates? An <i>in Vivo</i> Study With an Experimental Model of Foreign-Body InfectionCorinne Ruppen, Thomas Mercier, Denis Grandgirard, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 2024
Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infectionLaura Hermann, Verena Schöning, Sarah Dräger, et al.
Journal of Global Antimicrobial Resistance|October 31, 2021
Repatriation of a patient with COVID-19 contributed to the importation of an emerging carbapenemase producerAline I Moser, Edgar I Campos-Madueno, Parham Sendi, et al.
Springerplus|March 31, 2016
Mycoplasma-induced minimally conscious stateThomas Horvath, Urs Fischer, Lionel Müller, et al.
The Journal of Antimicrobial Chemotherapy|April 16, 2021
Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: a prospective cohort study of unbound plasma and individual MICsStephan Moser, Sophia Rehm, Nicolas Guertler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2023
Rifampin Based Therapy for Patients With Staphylococcus aureus Native Vertebral Osteomyelitis: A Systematic Review and Meta-analysisSaid El Zein, Elie F Berbari, Matteo Passerini, et al.
Infection and Immunity|May 21, 2008
Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humansLinda Johansson, Pontus Thulin, Parham Sendi, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2019
First Clinical Case of <i>In Vivo</i> Acquisition of DHA-1 Plasmid-Mediated AmpC in a Salmonella enterica subsp. <i>enterica</i> IsolateMathieu Clément, Peter M Keller, Odette J Bernasconi, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2015
In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to CefepimeJoão Pires, Magdalena Taracila, Christopher R Bethel, et al.
Antibiotics (Basel, Switzerland)|May 27, 2023
Penicillin-Susceptible <i>Streptococcus pneumoniae</i> Meningitis in Adults: Does the Ceftriaxone Dosing Matter?Samuel Raemy, Carlo Casanova, Rossella Baldan, et al.
Pageof 17